Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics, has secured seed funding from Atlas Venture and Novartis Venture Fund.Bicycle Therapeutics is a spin-out from the MRC Laboratory of Molecular Biology, Cambridge. The new company is managed by Dr. John Tite (Chief Executive Officer) and is based in Cambridge, UK.
As part of the funding, founding investors Dr. Regina Hodits, Atlas Venture, and Dr. Anja Koenig, Novartis Venture Fund, will join the Board of Directors.
FinSMEs
06/10/2009